HotAir hotair.com 21 Jul, 2021 19:15 am

How seriously should we take the new, pessimistic J&J vaccine study? – HotAir

How seriously should we take the new, pessimistic J&J vaccine study? – HotAir
Real world vs narrow lab results.

The new study published yesterday and reported by the New York Times certainly gives those of us who received this vaccine reason for some pause in relation to the surge in the Delta variant: The coronavirus vaccine made by Johnson & Johnson is much less effective against the Delta and Lambda variants than against the original virus, according to a new study posted online on Tuesday.The new study has not yet been peer reviewed nor published in a scientific journal.Antibody production is important in the first phase as a measure of efficacy, but other parts of the immune response are harder to measure.It might also miss other components of immune response, too.

It may still pay to get a cross-platform booster; I’ve considered doing that myself at some point, but want to wait for some data on how that will impact my immune response before going cowboy on the idea.Well, I’m certainly taking it seriously — as I got the Johnson & Johnson vaccine in March.

Read full story at hotair.com